Basic Information
| LncRNA/CircRNA Name | LINC-CBR1-2 |
| Synonyms | LINC01426, lincRNA-uc002yug.2 |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | lung cancer |
| ICD-0-3 | C34 |
| Methods | Microarray, qPCR, RNAi etc. |
| Sample | lung cancer tissues |
| Expression Pattern | up-regulated |
| Function Description | To validate our findings, we selected one lincRNA and three mRNAs for validation. Of these, linc-CBR1-2, and two mRNAs, RAB25 and HMBG3 were up-regulated in AIS compared to nomal tissue. |
| Pubmed ID | 24735754 |
| Year | 2014 |
| Title | Identification of mRNAs and lincRNAs associated with lung cancer progression using next-generation RNA sequencing from laser micro-dissected archival FFPE tissue specimens. |
External Links
| Links for LINC-CBR1-2 | GenBank HGNC NONCODE |
| Links for lung cancer | OMIM COSMIC |